We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Patients With Known or Suspected Heart Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00001313
First Posted: November 4, 1999
Last Update Posted: July 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Institutes of Health Clinical Center (CC)
  Purpose

In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI).

Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test.

These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.


Condition
Peripheral Artery Disease Coronary Disease Diabetes and Heart Failure Dilated Cardiomyopathy Heart Failure Renal Artery Stenosis Pulmonary Hypertension

Study Type: Observational
Official Title: Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date: May 10, 1992
Estimated Study Completion Date: January 6, 2009
Detailed Description:
The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:

  1. Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing.
  2. Cardiomyopathies including congestive phenotypes.
  3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia.
  4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
  5. Upper extremity peripheral artery disease.
  6. Diabetes with heart failure.
  7. Pulmonary hypertension.

EXCLUSION CRITERIA:

Pregnancy, for those patients who require catheterization-based diagnostics.

Inability to provide informed consent.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001313


Locations
United States, Maryland
Suburban Hospital
Bethesda, Maryland, United States, 20814
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
  More Information

ClinicalTrials.gov Identifier: NCT00001313     History of Changes
Other Study ID Numbers: 920189
92-H-0189
First Submitted: November 3, 1999
First Posted: November 4, 1999
Last Update Posted: July 2, 2017
Last Verified: January 6, 2009

Keywords provided by National Institutes of Health Clinical Center (CC):
Cardiac Diagnosis
Chest Pain
Hypertrophic Cardiomyopathy
Coronary Artery Disease
Microvascular Angina
Cardiac Investigation
Follow-up
Heart Disease

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiomyopathies
Hypertension, Pulmonary
Coronary Disease
Coronary Artery Disease
Peripheral Arterial Disease
Cardiomyopathy, Dilated
Renal Artery Obstruction
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Myocardial Ischemia
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Atherosclerosis
Peripheral Vascular Diseases
Cardiomegaly
Kidney Diseases
Urologic Diseases